Alberto MANTOVANI,Martina MOLGORA,Cecilia GARLANDA,Eduardo BONAVITA
申请号：
US16758136
公开号：
US20200281977A1
申请日:
2018.10.24
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention refers to a stably or transiently IL-1R8 deficient isolated human cell, being a natural killer (NK) cell or T cell and to their medical use, preferably in the treatment of tumours and infections.
